Moneycontrol PRO
HomeNewsEarumpharmace

At Moneycontrol, the Results page helps you effectively track corporate announcements and results for various listed companies across both India and abroad. With our Results page, you can keep abreast with an updated, comprehensive view of all the profit/loss statements, company spendings, AGM outcomes, and quarterly and annual results from all these listed companies. Additionally, Moneycontrol also regularly tracks international MNCs listed on NASDAQ and Asian bourses, including popular companies like Apple, Google, Alibaba. Apart from finding solid copies of company results, stock movements consequent to these company results, expectations, and analytical post results copies, you will also find copies and articles detailing the earnings, impact, and all major announcements made to media/exchanges by these companies, so that you do not miss anything. We also provide you with concrete data points to help you spot profitable trades, stock build-ups, and bulk deals. At Moneycontrol, we also cover analysts/investors meetings; scrutinise results and data and BSE/NSE reports or news. The copies are not just full of information and data, but are also adequately supplemented with expert views, investor opinions, extensive interviews, videos, and a huge variety of explainers, analyses, and informative slideshows to help you gauge the market and make investment decisions in the best possible manner. More

Jump to
  • Essel Propack Q1 PAT seen up 15.1% YoY to Rs. 48.3 cr: ICICI Direct

    Essel Propack Q1 PAT seen up 15.1% YoY to Rs. 48.3 cr: ICICI Direct

    Net Sales are expected to increase by 8.8 percent Y-o-Y (down 0.4 percent Q-o-Q) to Rs. 691.2 crore, according to ICICI Direct.

  • Essel Propack Q4 PAT seen up 10.8% YoY to Rs. 50.4 cr: ICICI Direct

    Essel Propack Q4 PAT seen up 10.8% YoY to Rs. 50.4 cr: ICICI Direct

    Net Sales are expected to increase by 8.6 percent Y-o-Y (down 1.7 percent Q-o-Q) to Rs. 682.6 crore, according to ICICI Direct.

  • Essel Propack Q3 PAT seen up 9.5% YoY to Rs. 44.6 cr: ICICI Direct

    Essel Propack Q3 PAT seen up 9.5% YoY to Rs. 44.6 cr: ICICI Direct

    Net Sales are expected to increase by 10.3 percent Y-o-Y (down 3.9 percent Q-o-Q) to Rs. 656.6 crore, according to ICICI Direct.

  • Essel Propack Q4 PAT seen up 14.9% YoY to Rs. 53 cr: ICICI Direct

    Essel Propack Q4 PAT seen up 14.9% YoY to Rs. 53 cr: ICICI Direct

    Net Sales are expected to increase by 10.5 percent Y-o-Y (up 13.7 percent Q-o-Q) to Rs. 676.6 crore, according to ICICI Direct.

  • Expect robust demand post implementation of GST: Essel Propack

    Expect robust demand post implementation of GST: Essel Propack

    In an interview to CNBC-TV18, Ashok Goel, VC & MD of Essel Propack spoke about the results and his outlook for the company.

  • See maintaining revenue, profit growth rate: Essel Propack

    See maintaining revenue, profit growth rate: Essel Propack

    In an interview with CNBC-TV18, Ashok Goel, VP and MD of Essel Propack said that higher volume has led to revenue growth in this quarter and the company aims to maintain its revenue growth at 15 percent and profit growth at 20 percent.

  • Look to grow non-oral care business in India: Essel Propack

    Look to grow non-oral care business in India: Essel Propack

    Revenue degrew for the last fiscal year because of divestment of its flexible packaging business and raw material pass through, said Ashok Goel VC & MD, Essel Propack.

  • Maintain 20% FY16 PAT growth guidance: Essel Propack

    Maintain 20% FY16 PAT growth guidance: Essel Propack

    The company undertook a strategic divestment during the quarter under review and the proceeds from the sale were used for debt repayment, which in turn helped in reducing financing cost, says Ashok Goel of Essel Propack

  • See EBITDA margins sustain around 18-20%: Essel Propack

    See EBITDA margins sustain around 18-20%: Essel Propack

    Ashok Goel, VC & MD of Essel Propack going forward is hopeful of clocking revenues of over Rs 500 crore.

  • Expect revenue to grow at 12% in FY16: Essel Propack

    Expect revenue to grow at 12% in FY16: Essel Propack

    In an interview to CNBC-TV18, Ashok Goel, VC & MD of Essel Propack, said the demand has softened in India, particularly in the FMCG space.

  • Essel Propack on track, new strategies yielding results

    Essel Propack on track, new strategies yielding results

    "The numbers are in-line with the guidance that we gave and are seeing a good growth. The EBITDA margins are what we promised to be 18 percent. Profit after tax (PAT) has also improved," says Ashok Goel, MD & vice chairman of the company in an interview to CNBC-TV18.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347